Isaac Cheng

Insider Reports History

Location
Boston, MA
Signature
/s/ Joshua B. Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Isaac Cheng:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Director Common Stock 10,415,650 $170,067,775 $16.33 06 Jan 2022 Indirect
Amylyx Pharmaceuticals, Inc. Director Common Stock 6,578 $107,406 $16.33 06 Jan 2022 Direct
Amylyx Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 19,000 09 Jun 2022 Direct
Amylyx Pharmaceuticals, Inc. Director Series A Preferred Stock 0 06 Jan 2022 Indirect
Amylyx Pharmaceuticals, Inc. Director Series B Preferred Stock 0 06 Jan 2022 Indirect
Amylyx Pharmaceuticals, Inc. Director Series C-1 Preferred Stock 0 06 Jan 2022 Indirect
Amylyx Pharmaceuticals, Inc. Director Series C-2 Preferred Stock 0 06 Jan 2022 Indirect

Insider Reports Filed by Isaac Cheng

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMLX Amylyx Pharmaceuticals, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:05
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 10 +$124,982 4 Director 10 Jan 2022, 19:35
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 0 $0 3 Director 06 Jan 2022, 16:09